| Pathway |
p-Value |
FDR |
Gene Symbol |
| MAPK signaling pathway |
6.40E-08 |
5.65E-06 |
MKNK2, CACNB4, EGF, HSPA1L, MOS, RASGRF2,
MAPK8IP3, CEBPZ, HSPA1A, HSPA1A, KRAS, MAPKAPK5,
PTPN7, TNF |
| Gap junction |
1.09E-04 |
6.33E-04 |
GNA11, EGF, ADCY2, CDC2, CDK1, KRAS, PDGFD |
| Cell adhesion molecules (CAMs) |
1.12E-04 |
6.33E-04 |
NRXN1, HLA-DQA2, HLA-F, HLA-DQA1, HLA-G,
PDCD1, PVRL2 |
| p53 signaling pathway |
0.002349 |
0.005206 |
ATR, GTSE1, CDC2, CDK1, MDM2 |
| Cytokine-cytokine receptor interaction |
0.005546 |
0.010259 |
EGF, BMP7, FLT4, CCL14, RELT, TNF, TNFSF13B |
| Notch signaling pathway |
0.006421 |
0.0117 |
NCOR2, CTBP2, JAG2 |
| GnRH signaling pathway |
0.011063 |
0.017584 |
GNA11, PLD1, ADCY2, KRAS |
| T cell receptor signaling pathway |
0.011779 |
0.01834 |
PDCD1, CARD11, KRAS, TNF |
| Acute myeloid leukemia |
0.011996 |
0.01856 |
JUP, KRAS, RUNX1T1 |
| Mismatch repair |
0.014568 |
0.021396 |
CDC2, MSH2 |
| B cell receptor signaling pathway |
0.022695 |
0.028704 |
CARD11, FCGR2B, KRAS |
| Chronic myeloid leukemia |
0.022695 |
0.028704 |
CTBP2, KRAS, MDM2 |
|
